5 results
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis - Induction, Consolidation and Maintenance Therapy

Table 2. Antifungal Treatment Recommendations
for Cryptococcal ... and Maintenance Therapy ... Recommendations for Cryptococcal ... #Treatment #management ... #meningitis #cryptococcus
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... for Cryptococcal ... week) >1 year #Cryptococcal ... #Treatment #management ... #meningitis #cryptococcus
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Transplant Recipients
Induction therapy:
 • liposomal AmB (3–4 mg/kg per
IDSA Treatment Recommendations ... for Cryptococcal ... year B-III #Cryptococcal ... #Treatment #management ... #meningitis #cryptococcus
Dual Targeted Therapy (DTT) in IBD - IBD Algorithm

Indication for DTT:
 • Refractory
 • Failed multiple
Dual Targeted Therapy ... IBD Algorithm ... #IBDAlgorithm # ... IBD #Algorithm # ... gastroenterology #management
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... Induction Therapy ... Cryptococcosis #Cryptococcus ... #IDSA #Prevention ... #Treatment #management